title: Effect of Linagliptin on Arterial18F-Fluorodeoxyglucose Positron Emission Tomography Uptake: A Randomized Controlled Trial (RELEASE).
authors.forename: Stefanie A
authors.initials: SA
authors.lastname: de Boer
authors.forename: Hiddo J L
authors.initials: HJ
authors.lastname: Heerspink
authors.forename: Joop D
authors.initials: JD
authors.lastname: Lefrandt
authors.forename: Marieke C
authors.initials: MC
authors.lastname: Hovinga-de Boer
authors.forename: Arie M
authors.initials: AM
authors.lastname: van Roon
authors.forename: Luis E
authors.initials: LE
authors.lastname: Juárez Orozco
authors.forename: Andor W J M
authors.initials: AW
authors.lastname: Glaudemans
authors.forename: Pieter W
authors.initials: PW
authors.lastname: Kamphuisen
authors.forename: Riemer H J A
authors.initials: RH
authors.lastname: Slart
authors.forename: Douwe J
authors.initials: DJ
authors.lastname: Mulder
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001158:Arteries / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D050197:Atherosclerosis / Q000175:diagnosis* / Q000378:metabolism / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D000069476:Linagliptin / Q000008:administration & dosage*; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D016032:Randomized Controlled Trials as Topic; D059289:Vascular Stiffness / Q000502:physiology
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D000069476:Linagliptin